39.46
price up icon0.77%   0.30
after-market Handel nachbörslich: 39.70 0.24 +0.61%
loading
Schlusskurs vom Vortag:
$39.16
Offen:
$39.04
24-Stunden-Volumen:
2.42M
Relative Volume:
0.59
Marktkapitalisierung:
$16.73B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
17.18
EPS:
2.297
Netto-Cashflow:
$827.02M
1W Leistung:
+1.28%
1M Leistung:
+6.62%
6M Leistung:
+15.99%
1J Leistung:
+52.95%
1-Tages-Spanne:
Value
$38.98
$39.51
1-Wochen-Bereich:
Value
$38.82
$40.01
52-Wochen-Spanne:
Value
$24.05
$41.24

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
Firmenname
Royalty Pharma Plc
Name
Telefon
(212) 883-0200
Name
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Name
Mitarbeiter
99
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-11
Name
Neueste SEC-Einreichungen
Name
RPRX's Discussions on Twitter

Vergleichen Sie RPRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RPRX
Royalty Pharma Plc
39.46 16.73B 2.31B 1.66B 827.02M 2.297
Biotechnology icon
ARGX
Argen X Se Adr
918.53 57.24B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.52 110.12B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
INSM
Insmed Inc
201.62 42.10B 447.02M -1.18B -906.14M -6.1812
Biotechnology icon
ONC
Beone Medicines Ltd Adr
363.92 41.68B 4.98B 69.59M 525.67M 0.5197
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
725.34 74.02B 14.25B 4.58B 3.88B 41.77

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-30 Eingeleitet Goldman Buy
2025-05-16 Eingeleitet Morgan Stanley Overweight
2024-06-03 Herabstufung UBS Buy → Neutral
2022-06-14 Fortgesetzt UBS Buy
2022-05-13 Eingeleitet Scotiabank Sector Outperform
2022-04-27 Eingeleitet Goldman Buy
2022-04-14 Hochstufung JP Morgan Neutral → Overweight
2022-04-06 Fortgesetzt Morgan Stanley Overweight
2021-10-29 Hochstufung Citigroup Neutral → Buy
2021-07-30 Eingeleitet Tigress Financial Buy
2020-11-09 Hochstufung UBS Neutral → Buy
2020-07-14 Eingeleitet Evercore ISI In-line
2020-07-13 Eingeleitet BofA Securities Buy
2020-07-13 Eingeleitet Citigroup Neutral
2020-07-13 Eingeleitet Cowen Outperform
2020-07-13 Eingeleitet Goldman Neutral
2020-07-13 Eingeleitet JP Morgan Neutral
2020-07-13 Eingeleitet Morgan Stanley Equal-Weight
2020-07-13 Eingeleitet SunTrust Buy
2020-07-13 Eingeleitet UBS Neutral
Alle ansehen

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

pulisher
04:13 AM

How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves - Yahoo Finance

04:13 AM
pulisher
01:19 AM

Will Royalty Pharma plc (RPD) stock maintain strong growthDividend Hike & Reliable Trade Execution Plans - newser.com

01:19 AM
pulisher
09:49 AM

Vise Technologies Inc. Takes Position in Royalty Pharma PLC $RPRX - MarketBeat

09:49 AM
pulisher
07:48 AM

Why Royalty Pharma plc (RPD) stock could break out in 20252025 Macro Impact & Technical Confirmation Alerts - newser.com

07:48 AM
pulisher
07:24 AM

Ontario Teachers Pension Plan Board Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat

07:24 AM
pulisher
07:12 AM

Published on: 2025-11-18 06:12:54 - newser.com

07:12 AM
pulisher
05:24 AM

Will Royalty Pharma plc (RPD) stock hit Wall Street targetsOil Prices & Real-Time Stock Entry Alerts - newser.com

05:24 AM
pulisher
04:26 AM

Is Royalty Pharma plc (RPD) stock attractive post correctionJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com

04:26 AM
pulisher
04:25 AM

Top chart patterns to watch in Royalty Pharma plcPortfolio Return Summary & Long-Term Capital Growth Ideas - newser.com

04:25 AM
pulisher
Nov 17, 2025

Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Forsta AP Fonden Reduces Stake in Royalty Pharma PLC $RPRX - MarketBeat

Nov 17, 2025
pulisher
Nov 17, 2025

Geode Capital Management LLC Has $299.49 Million Position in Royalty Pharma PLC $RPRX - MarketBeat

Nov 17, 2025
pulisher
Nov 17, 2025

What indicators show strength in Royalty Pharma plc2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

What analysts say about Royalty Pharma plc stockShort-Term Trading Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in

Nov 17, 2025
pulisher
Nov 16, 2025

What’s the recovery path for long term holders of Royalty Pharma plc - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Analyzing net buyer seller activity in Royalty Pharma plcJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What MACD signals say about Royalty Pharma plcTrade Risk Assessment & Low Risk High Reward Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can Royalty Pharma plc stock rebound after recent weaknessPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat

Nov 16, 2025
pulisher
Nov 15, 2025

Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Rally & Free Safe Capital Growth Stock Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why analysts remain bullish on Royalty Pharma plc stockDollar Strength & Long-Term Growth Portfolio Plans - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Applying chart zones and confluence areas to Royalty Pharma plcInsider Selling & Free Daily Entry Point Trade Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Quantitative breakdown of Royalty Pharma plc recent moveMarket Growth Report & Reliable Trade Execution Plans - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Nov 15, 2025
pulisher
Nov 15, 2025

Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha

Nov 15, 2025
pulisher
Nov 14, 2025

Why retail investors pile into Royalty Pharma plc stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Is Royalty Pharma plc (RPD) stock a buy during volatile marketsVolume Spike & Verified Chart Pattern Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Is Royalty Pharma plc stock a top momentum playQuarterly Market Review & Fast Gain Swing Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025
pulisher
Nov 14, 2025

What drives Royalty Pharma plc stock priceResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in

Nov 14, 2025
pulisher
Nov 14, 2025

How Royalty Pharma plc (RPD) stock performs in easing cyclesEarnings Growth Report & Community Trade Idea Sharing - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Mitsubishi UFJ Trust & Banking Corp Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025
pulisher
Nov 13, 2025

Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Nov 13, 2025
pulisher
Nov 12, 2025

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance

Nov 12, 2025

Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Royalty Pharma Plc-Aktie (RPRX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Norden Gregory
Director
Aug 11 '25
Sale
36.23
33,500
1,213,749
194,848
$30.32
price down icon 0.33%
$20.52
price down icon 0.19%
$70.58
price up icon 2.08%
$102.53
price down icon 0.14%
$725.34
price up icon 2.99%
Kapitalisierung:     |  Volumen (24h):